Results 81 to 90 of about 209 (167)

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

BJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan, David Homewood, Harrison Lucas, Brendan Dittmer, Jiasian Teh, Jonathan S. O'Brien, Jianliang Liu, Ben Tran, Justin Chee, James A. Churchill, Nathan Lawrentschuk, Niall M. Corcoran   +11 more
wiley   +1 more source

Use of parallel fluorescent confocal microscopy for detection of prostatic adenocarcinoma

BJU International, EarlyView.
Objective To provide a histological catalogue and defined criteria for the diagnosis of prostatic adenocarcinoma and its variants using the fluorescent confocal microscope (FCM) platform. Methods A total of 22 radical prostatectomy specimens were serially sectioned and scanned with the FCM.
Kevin Clare, Kenneth Haines, Jeremy Littlefield, Asher Mandel, Hannah Sur, Neeraja Tillu, Henry Jodka, Daniel Ajabshir, Fatima Ahmad, Chahat Arora, Cristina Pasat‐Karasik, Monali Fatterpekar, Ash Tewari, Ming Zhou   +13 more
wiley   +1 more source

Bladder urothelial neoplasms in pediatric age: Experience at three tertiary centers

, 2014
INTRODUCTION: Urothelial bladder neoplasms (UBN) typically occur in patients in their sixth or seventh decade of life while they are infrequent in children and young adults.
Manzoni G, Caione, P., Castagnetti M., Nappo S. G., Berrettini A, Nappo, S. G., Caione P., Nappo SG, Caione P, Rigamonti W., RIGAMONTI, WAIFRO, Berrettini, A., Salerno, A., Rigamonti W, Salerno A., Castagnetti, M, Berrettini A., Manzoni G., Salerno A, Manzoni, G., Castagnetti M   +20 more
core   +1 more source

Postoperative care of neobladder using a detubularized intestinal segment [PDF]

, 1995
Neobladder using a detubularized intestinal segment was constructed in 74 cystectomized patients between October 1986 and July 1994. There were 65 males (87.8%) and 9 females (12.2%) with an average age of 63 years (range 36 to 77 years). The mean follow-
岡田, 弘, 下垣, 博義, 荒川, 創一, 中村, 一郎, 守殿, 貞夫, 川端, 岳, 江藤, 弘, 山中, 望   +7 more
core  

The Human Female Prostate—Immunohistochemical Study with Prostate-Specific Antigen, Prostate-Specific Alkaline Phosphatase, and Androgen Receptor and 3-D Remodeling

, 2011
Introduction The constitution of glands surrounding the human female urethra has been under debate; especially regarding as to what extent they equal the male prostate.
W. Dietrich, M. Susani, L. Stifter, A. Haitel   +3 more
core   +1 more source

Association of different treatment modalities for rectal cancer and second primary urinary system neoplasms, findings from SEER

Scientific Reports
This study aimed to evaluate the risk of secondary primary urinary system neoplasms (SPUNs) in patients undergoing different treatment strategies during the perioperative period of rectal cancer (RC) and evalue survial prognostsis of SPUNs. The data were
Na Li, Xuning Wang, Fuxiao Duan, Xinyu Wang, Cheng Zhang   +4 more
doaj   +1 more source

Urethral and bladder dosimetry and urinary toxicity in prostate cancer patients undergoing SBRT with and without intra-prostatic boost

Clinical and Translational Radiation Oncology
Background and purpose: To evaluate the dosimetric and toxicity profiles of stereotactic body radiotherapy (SBRT) for prostate cancer, comparing cohorts with and without intraprostatic boost (IPB) to assess feasibility and safety of IPB, with particular ...
Nisha Bhargava, Martina Hurwitz, Josephine Levey, Lily Bennett, Joseph A. Aronovitz, Daniel R. Schmidt, Jonathan W. Lischalk, Irving D. Kaplan, Nima Aghdam   +8 more
doaj   +1 more source

First‐In‐Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck

Cancer Science, EarlyView.
The dose escalation part of the first‐in‐human study of E7130 in patients with advanced solid tumors determined the Recommended Phase 2 Dose of E7130 (480 μg/m2 Q3W). The dose expansion part (presented here) examined safety/preliminary efficacy in patients with squamous cell carcinoma of the head and neck and urothelial carcinoma.
Nobuaki Matsubara, Ken Saijo, Yasushi Shimizu, Susumu Okano, Kenji Nakano, Naoki Nishio, Tomoyuki Otsuka, Hirofumi Kuno, Takuma Miura, Tomoki Kubota, Hiroki Ikezawa, Yuko Umetsu, Ken Ito, Abraham Apfel, Yuanqing Ye, Yoshitaka Honma   +15 more
wiley   +1 more source

A study on removal of urethral catheter on Post-OP day 2 Vs the conventional post-OP day 4 after TURP. [PDF]

, 2012
INTRODUCTION : The prostate is the most common site of urological disease in man. It is also the male organ most commonly affected with either benign or malignant neoplasms.
Jason Philip, D
core  

TREM2 in Macrophages Promotes Renal Fibrosis via Activation of β‐Catenin Signalling Pathway in Obstructive Nephropathy

Cell Proliferation, EarlyView.
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) promotes obstructive nephropathy progression by activating the β‐catenin signalling pathway, driving M2 macrophage polarisation, migration and fibrogenic gene expression. targeted inhibition of TREM2 thus represents a promising novel strategy against renal fibrosis.
Jia Wei, Zixia Li, Gengyu Du, Ting Chen, Min Yang, Zhen Yuan, Yidan Zheng, Xiang Yan   +7 more
wiley   +1 more source